Navigation Links
Gene variants hold clues about vulnerability to cardiovascular disease

Researchers led by Duke University Medical Center scientists have discovered that alterations in a gene that triggers other genes may hold clues to the reasons why// certain people are vulnerable to heart disease. This gene termed, as GATA2 and the army of genes it manipulates may actually show an individual’s propensity to coronary artery disease. This finding may also show the way for the invention of genetic tests that can forecast an individual’s likelihood of developing coronary artery disease, the scientists said.

"We hope that one day it will be possible to use these gene variations to predict who is susceptible to cardiovascular disease," said Jessica J. Connelly, a postdoctoral fellow at the Duke Center for Human Genetics and lead author on the study. "This finding is the first step before we can develop such a test for use in patients."

People who know they are at higher risk may be encouraged to take early steps to modify behaviors, such as smoking or consuming foods high in saturated fats, that are known to play a role in promoting heart disease, the scientists said.

The team reports its findings in the August 2006 issue of Public Library of Science (PLoS) Genetics. The research was sponsored by the National Institutes of Health.

Coronary artery disease affects more than 13 million Americans and is one of the nation's leading causes of death. The disease occurs when the arteries supplying blood to the heart become narrowed or clogged by plaque deposits. Left untreated, the disease can completely block the blood flow to the heart, leading to a heart attack.

Coronary artery disease is what scientists call a "complex" genetic disease – that is, it results from the accumulation of a number of small genetic changes that influence an individual's ability to cope with environmental and biological effects. While risk factors such as smoking, high blood pressure and high cholesterol are known to contri
'"/>




Page: 1 2 3 4

Related medicine news :

1. New clues about immune system from leprosy microbes
2. New clues to maternal aggressive behavior
3. Monkeys offer genetic clues to adult blindness
4. Transporter offers reliable clues for safer pain medicine
5. More about HIV
6. Teens listen to parents about smoking
7. Spreading knowledge to doctors about herbal medicine
8. A new discovery about Acetaminophen
9. A new discovery about Acetaminophen
10. An insight about Schizophrenia
11. FDA to bring about changes in Marketed Non-Steroidal Anti-Inflammatory Drugs
Post Your Comments:
(Date:10/15/2008)... Will Educate Parents about Prescription,Drug Abus...mily Partnership (NFP),has designated Monday, Octo...g off the group,s 23rd annual Red Ribbon Week from...ents with action steps to prevent children,s,presc...million teens in the United States abuse,prescript...
(Date:10/14/2008)...4 /PRNewswire-USNewswire/ -- Kerby T.,Alvy, Ph.D.,...r for the,Improvement in North Hollywood (CICC), h... and Prevention (CDC) to serve as an expert to inf...or the prevention of child,maltreatment., CDC,s n...lationships,(SSNR) as the foundation for a unified...
(Date:10/14/2008)...ker Founder and CEO Andrew Levitt to showcase Heal... Somerville, MA (PRWEB) Octob... , the word-of-mouth marketing (WOM) firm for the ... announced that Andrew Levitt, Founder and CEO of ...Pharma and Health 2.0" at Health 2.0: User-Ge...
(Date:10/14/2008)...PRNewswire-FirstCall/ -- Warner Chilcott,Limited (... its third quarter,2008 financial results prior to... In addition to issuing a press release, the Comp... parties on Monday, November 10, 2008 at,8:00 AM (...e in the call,please dial (877) 856-1955 in the U...
Breaking Medicine News(10 mins):Health News:National Family Partnership Designates October 27th 'Lock Your Meds' Day 2Health News:National Family Partnership Designates October 27th 'Lock Your Meds' Day 3Health News:Los Angeles Psychologist to Help CDC Fight Child Abuse 2Health News:HealthTalker Founder and CEO Andrew Levitt to be Featured at 'Health 2.0: User-Generated Healthcare 2008' 2
...econd largest AIDS capital in the United States. T...ics//. However its been found that primary care pr... are often failing to offer either HIV testing or ...a new UCLA AIDS Institute study. Hence AIDS cases ...
...chronic diseases], more people can live longer.'Ra...vent and treat diseases are bringing// closer the ...tential to live 100 years or longer, said Dr. Pasc...ty of Miami Miller School of Medicine. ''In five ...
...wmakers -- including Sens. Debbie Stabenow (D-Mich... Cubin (R-Wyo.) and Lois Capps (D-Calif.) -- earli...1014) that aims to improve heart disease education...d increase women's access to heart disease screeni...
...t study, the ages at which teenagers and children ...e a significant impact on their delinquent behavio... is a case of first intercourse earlier than their...was published in February edition of the Journal o...
Other Medicine News:Health News:Primary Health Care Parishioners of Second Largest HIV Infected Area in US Fail to Offer HIV Tests 2Health News:Primary Health Care Parishioners of Second Largest HIV Infected Area in US Fail to Offer HIV Tests 3Health News:Genetics Might Engineer Path to Successful Aging 2
(Date:10/14/2008)...4 /PRNewswire-USNewswire/ -- Susan G. Komen for th...n unprecedented $100,million in grants to American...ast track breast cancer research. Grants were also... from the Barbara Ann Karmanos Cancer Institute an... Boerner, Ph.D., assistant,professor, and Guojun W...
(Date:10/14/2008)...t. 10 /- Regado Biosciences, Inc.,an... in the Phase IIa,clinical study of its REG1 Antic...percutaneous coronary intervention (PCI). REG1 is ...d anticoagulant, RB006, and its matched,active re...nd neutralizes,RB006. The Phase IIa study (REVERSA...
(Date:10/13/2008)... million dollar NIH funding advances study S... rates, MINNEAPOLIS, Oct. 13 /- Adva...edcirculatory.com ) announced today that it has re...the National Institutes of,Health (NIH) to continu...on,those who experience cardiac arrest outside a h...
(Date:10/13/2008)...nnounce Interim Results in January 2009 and Final ..., EMERYVILLE, Calif., Oct. 13 /PRNewswire-FirstCa... (Nasdaq: NTII ) today announced that following a...n to discuss the,Viprinex(TM) (ancrod) Phase 3 cli...ny plans to consolidate and analyze data from its ...
Breaking Medicine Technology:Susan G. Komen for the Cure(R) Makes Unprecedented Research and Local Program Grants 2Susan G. Komen for the Cure(R) Makes Unprecedented Research and Local Program Grants 3Susan G. Komen for the Cure(R) Makes Unprecedented Research and Local Program Grants 4Susan G. Komen for the Cure(R) Makes Unprecedented Research and Local Program Grants 5Regado Biosciences Completes Patient Enrollment for Phase IIa Study of REG1 Anticoagulation System 2Regado Biosciences Completes Patient Enrollment for Phase IIa Study of REG1 Anticoagulation System 3Whatcom County, Washington Participating in NIH Study of Cardiac Arrest Resuscitation Techniques 2Neurobiological Technologies Announces FDA Agreement to Consolidate Viprinex Phase 3 Trials Accelerating Time to Pivotal Data 2Neurobiological Technologies Announces FDA Agreement to Consolidate Viprinex Phase 3 Trials Accelerating Time to Pivotal Data 3Neurobiological Technologies Announces FDA Agreement to Consolidate Viprinex Phase 3 Trials Accelerating Time to Pivotal Data 4Before Every Surgery Take a TIME OUT 28R 29 5745 1Before Every Surgery Take a TIME OUT 28R 29 5745 2Black Athletes Hearts May Differ From Those of Whites 20899 1Black Athletes Hearts May Differ From Those of Whites 20899 2Black Athletes Hearts May Differ From Those of Whites 20899 3Katzen Eye Group Announces a New Option in Vision Correction Technology for Patients 20895 1Katzen Eye Group Announces a New Option in Vision Correction Technology for Patients 20895 2Olympic Champion Mary Lou Retton and ASCO Join Frosted Pink with a Twist to Empower Women Through Education and Advocacy 20891 1Olympic Champion Mary Lou Retton and ASCO Join Frosted Pink with a Twist to Empower Women Through Education and Advocacy 20891 2Olympic Champion Mary Lou Retton and ASCO Join Frosted Pink with a Twist to Empower Women Through Education and Advocacy 20891 3Olympic Champion Mary Lou Retton and ASCO Join Frosted Pink with a Twist to Empower Women Through Education and Advocacy 20891 4
...ated for the treatment of plantar fasciitis and Ac...ply. The splint features adjustable dorsiflexion a... nightly contractures and tightening of the planta... flexibility in the treatment of the problem by al...
Comfortably positions the affected foot at 90 to provide continuous and effective stretching of the plantar fascia and Achilles Tendon
Bird and Cronin, Inc. is a leading manufacturer of Patient Footwear, Orthopedic Softgoods, and Specialty Patient Care Products. Our products are of the highest quality and available in the USA and In
... compression and cold, the Foot Cryo/Cuff minimize...ly designed cuff provides complete foot coverage f...ed as a single cuff, or with a cooler (including a... available separately and can be used with any mod...
Medicine Products: